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Non-neoplasticAbstract Objectives: Our aim was to evaluate the efﬁcacy of MR Spectroscopy in characteriza-
tion of white matter signal abnormalities diagnosed by MRI detect changes in different metabolites
and peaks of inﬂammation.
Patients and methods: 93 patients (49 females and 44 males) age ranging from 2 to 63 years with
average (37 ± 2.34 years) presented with white matter hyperintense lesions on T2 and T2 FLAIR
and/or contrast enhanced T1WI diagnosed on MRI are included our study.
Results: In Infectious group: Average Cho/NAA ratio: 0.79 ± 0.19, Cho/Cr ratio: 0.95 ± 0.17,
NAA/Cr 1.89 ± 0.69, in inﬂammatory group Cho/NAA ratio: 0.65 ± 0.15, Cho/Cr ratio: 0.98
± 0.29, Average NAA/Cr ratio 1.69 ± 0.19. In ischemic group: Average Cho/NAA ratio: 0.83
± 0.09, Cho/Cr ratio: 0.81 ± 0.23, Average NAA/Cr 1.54 ± 0.39, in metabolic group: Average
Cho/NAA ratio: 0.57 ± 0.13, Cho/Cr ratio: 0.76 ± 0.26; NAA/Cr ratio was 1.73 ± 0.44, in mito-
chondrial group, Average Cho/NAA ratio: 0.62 ± 0.19, Cho/Cr ratio: 0.54 ± 0.14, NAA/Cr ratio
was 1.49 ± 0.59, in inherited dysmyelinating; Cho/NAA ratio: 0.51 ± 0.17, Cho/Cr ratio: 0.63
± 0.13; Average NAA/Cr ratio was 1.87 ± 0.65. Glutamate and myoinositol peak raised in inﬂam-
matory, infectious, metabolic, inherited, and ischemic group mainly in the acute and subacute stage.
Amino acids and succinate peak speciﬁcally are raised in brain abscesses.
Conclusion: MRS is a noninvasive additional MRI technique to deﬁne the nature of non-neoplastic
brain lesions. Together with image analysis, it may be the key to etiologic diagnosis or, at least, def-
inition of the group where the lesion is classiﬁed, by detecting changes in different metabolites and
peaks of inﬂammation.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
White matter lesions may be demyelinating with loss of
normally formed myelin, classiﬁed as infectious, inﬂammatory,
metabolic, vascular, neoplastic or dysmyelinating: inherited
Table 1 Pathology classiﬁcation of white matter diseases.
White matter lesions: Infectious (33): 35.48% TB: 6
Demyelinating: Cysticercosis: 4
Infectious Encephalitis:14
Inﬂammatory Encephalitis with ventriculitis: 2
ischemic Abscesses: 7
Metabolic
Dysmyelinating Inﬂammatory (22): 23.65% Chronic MS: 12
Mitochondrial Acute MS: 4
Inherited ADEM: 6
ischemic (29): 31.18% 17: infarction (in diﬀerent stages)
12 hematoma (in diﬀerent stages
Metabolic (2): 2.15% Wilson disease: 2
Mitochondrial (4)::4.31% Leigh disease 4
Inherited (3): 3.22% Metachromatic leukodystrophy(MLD): 3
Total no of patient 93 patients
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of myelin (see Table 1) (1). MR spectroscopy has the poten-
tial for discriminating the presence and relative amount of var-
ious chemical metabolites in the brain and is therefore a useful
technique to further assess various intracranial diseases, partic-
ularly to speciﬁcally determine which major category of disease
is manifested by the observed lesion (e.g., neoplastic, inﬂam-
matory, ischemic (2)). The aim of our study was to assess meta-
bolic changes by MRS of different white matter diseases
diagnosed by MRI and evaluate peaks of inﬂammation.
2. Patients and methods
The study population included a total of 93 patients, 49
females and 44 males with age ranging from 2 to 63 years, with
total number of 258 examined white matter hyperintense
lesions on T2, FLAIR and/or contrast enhanced MRI
sequences diagnosed on MRI lesions, 68 with single bilateral
lesions and 25 with multiple bilateral lesions. This study was
performed after the approval of the faculty ethical committee,
and informed written consent was obtained from all patients
or patient’s parents. During a period from January 2014 to
July 2015, 93 patients (44 males and 49 females), age ranging
from 2 to 63 years (mean 37 ± 2.34) were included in this
study. All had a focal white matter diseases recently diagnosed
by MRI and had received no previous treatment, except for
steroids. They were referred for MRS examination before
starting treatment. All patients were subjected to history tak-
ing, clinical examination, MRI and MRS examinations and
ﬁndings are correlated with laboratory, response to treatment
received by the patient, and/or follow-up by MRI and MRS
examinations with histopathology correlation if available.
The spectroscopic data were processed on a Philips 1.5 Tesla
workstation (Gyroscan Entera, Philips medical systems) using
standard imaging head coil. Images were acquired with the
patient on supine position with a placed head support pillow
to minimize the patient’s movement. The procedure was
explained carefully to the patients. They were asked to relax
and stay still during the examination, and oral administration
of chloralhydrate (50 mg/kg body weight) was given to sedate
young patients during the exam. The volume of interest (VOI)
was determined by T2 FLAIR and/or contrast enhanced axial
T1-weighted images simultaneously to ensure that voxels wereplaced over the whole area of signal alteration, and the voxel
was centered on the region previously noted including the
bilateral basal ganglia, thalami, white matter, ventricles, brain
stem substantia nigra cranial nerves and red nuclei, to correspond
to area ofmaximal T2 or T2FLAIR abnormality andmass effect
or maximum contrast enhancement. The size of the voxel ranged
from 1  1  1 cm3 to 2  2  2 cm3 according to the size of the
lesion, and the time of the whole MRS examination using the
single voxel technique ranged from 40 min.
Three TE acquisitions sequences (long, short and interme-
diate TEs) were done. SVS studies were performed with Point
Resolve Spectroscopy sequence (PRESS).
MRS technique: First: Axial, sagittal and coronal planes of
the brain were done in T2WI:TE = 100, TR = 3658, Field of
view (FOV) 18  24 cm and Matrix 192  256.
Then, MRS in long TE = 288, short TE = 31 and interme-
diate TE = 144 with TR = 2000 and spectral bw = 1000. The
long TE spectrum was to evaluate Cho, NAA, Cr and lipid lac-
tate peak. The short TE spectrum was to evaluate myoinositol,
glycine and glutamate, succinate and amino acid peaks.
The signal intensity of various metabolite peaks was evalu-
ated in every voxel by using the integral of each peak as a mea-
sure of its intensity. Metabolite ratios for Cho/NAA, Cho/Cr,
NAA/Cr ratio, and Glx, mI and peak were automatically cal-
culated in each voxel of whole area of signal alteration includ-
ing the contrast-enhancing area (when present). Succinate lac/
Cr ratio and amino acid peak were studied in speciﬁc cases.
The statistical analysis of data was done using SPSS (Statis-
tical Package for Social Science, version 16 Inc., Chicago, IL)
program software package for windows. The mean and SD
value of the metabolite ratios for different white matter lesions
diagnosed by MRS was calculated.
3. Results
Cho/Cr and Cho/NAA ratios were lower and NAA/Cr ratio
was higher compared to the expected ratios in neoplastic brain
lesions (Table 2). Dominant metabolite for ischemic lesions,
was the Lip/Lac that was also consistent in the ischemic
lesions.
In demyelinating diseases, we had reliably increased
myoinositol (MI) peaks, and the metabolic disease group
showed raised glutamate (Glx) peak.
Table 2 Mean and standard deviation of main metabolite
ratios in different white matter diseases.
White matter lesions Cho/NAA Cho/Cr NAA/Cr
Infectious 0.79 ± 0.19 0.95 ± 0.17 1.89 ± 0.69
Inﬂammatory 0.65 ± 0.15 0.98 ± 0.29 1.69 ± 0.19
ischemic 0.83 ± 0.09 0.81 ± 0.23 1.54 ± 0.39
Mitochondrial 0.62 ± 0.19 0.54 ± 0.14 1.49 ± 0.59
Metabolic 0.57 ± 0.13 0.76 ± 0.26 1.73 ± 0.44
Inherited 0.51 ± 0.17 0.63 ± 0.13 1.87 ± 0.65
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lous abscesses, and elevated Cho levels and reduced NAA
levels had been reported in acute MS plaques.
Creatine (Cr) is considered to be an indicator of energy
metabolism, generally decreased in chronic MS plaques,
increased in acute MS and in glial tumors, Glx glutamate
and myoinositol peak raised in inﬂammatory and infectious
groups especially in the acute stage, Glx is high in all acute
MS cases (Table 3), mildly raised in 2 out of 12 chronic MS
and in 2 out of 6 cases of ADEM and reduced in 10 out of
12 chronic MS and 4 out of 6 of ADEM, Glx is high in all
cases of TB, mildly raised in encephalitis, high in all acute
and subacute and low in chronic ischemic cases.Fig. 1 Female patient 24 years old with acute MS (A) Axial MR
hyperintense lesion, (B) and (C) MRS at long and short TR showed: E
arrow), with elevated cho/Cr.
Table 3 Other metabolite changes in white matter diseases.
White matter
lesions
Glx peak MI peak
Infectious +++ in TB +in TB brain abscesses
encephalitis+ in encephalitis
Inﬂammatory +++ in acute MS +++ in acute MS
+ in chronic MS and
ADEM
+ in chronic MS
 in chronic MS
and ADEM
 in ADEM
Ischemic ++ in acute and
subacute
++ in acute and subacute
 in chronic cases  in chronic
Mitochondrial + +
Metabolic + ++
Inherited ++ +++In cases of ischemia, we had raised choline level in all cases
of the acute and subacute stage and 7 out of 14 of chronic
stage, increased MI in the acute and subacute stage, and MI
is also high in acute MS, raised in TB, brain abscesses,
encephalitis, and low in chronic ischemia and ADEM. Lac is
produced in anaerobic glycolysis and is more prominent in
ischemic diseases and acute infarction, Lac/Cr ratio in MLD
ranges from 0.2 to 0.4.
Lip usually correlateswith the extent of tissue short relaxation
time seen in acute MS plaques and brain abscesses, and Lip–Lac
metabolites routinely were undetectable in healthy brain.
Mitochondrial lesions (Leigh’s disease) showed in average ele-
vated choline, occasionally elevated lactate and reduced NAA.
Amino acids and succinate peak raised in all brain
abscesses with mild increase in cysticercosis.
In metabolic group, MI and Glx were increased with lipid/
lactate peak which is also noted.
4. Discussion
MRS contributed to correct diagnosis of encephalic lesions
with diverse etiologies, such as infectious, ischemic, demyeli-
nating, inﬂammatory, malformation of brain development
and phacomatosis (3).I brain T2 weighted FLAIR images showed left basal ganglia







++ in TB, brain Abscesses,
encephalitis

+ cysticercosis  cysticercosis
 + in ADEM 
 ++ in acute and subacute 




236 R.O. Kaddah, M.E. KhalilNAA is a marker of functional neurons and decreases in all
kinds of brain damages whether it is inﬁltrative, degenerative or
destructive processes (4). Cho resonances increase in acute MS
plaques and tuberculous abscesses due to increased cell mem-
brane synthesis and turnover (5,6). Cr is considered to be an
indicator of energy metabolism, generally increased in chronic
MS plaques and decreased in acute MS (7–9). Lac is produced
in anaerobic glycolysis and is more prominent in ischemic dis-
eases and acute infarction, and Lip usually correlates with the
extent of short relaxation time of tissue, generally seen in acute
MS plaques and brain abscesses. Lip–Lac metabolites routinely
were undetectable in healthy brain (10–12). Glx is a neurotrans-
mitter, generally increased in Wilson disease; elevated Cho
levels and reduced NAA levels had been reported in acute
MS plaques and had been explained by reactive astrogliosis,
inﬂammation and early axonal degeneration, and MI at short
TE was also a discriminating metabolite for the acute MS
and also increased in cases of glial activation or gliosis (13) in
Multiple sclerosis: in acute lesions there is an elevation of
glutamate in contrast-enhancing areas This is consistent with
active inﬂammatory inﬁltrates (Fig. 1). It can be seen as a
new in vivo marker of inﬂammation (14), they are also
characterized by lac increase, depending on the degree of
inﬂammatory reaction, increased Cho/Cre ratios are due toFig. 2 Female patient 36 years old with chronic MS (A) Axial MRI
(B) and (C) MRS at long and short TR showed: Reduced glutamate
arrow), and reduced NAA/Cr ratio.
Fig. 3 Female patient 28 years old with acute disseminated encephal
bilateral periventricular hyperintense lesions, (B) and (C) MRS at long
no MI detected.acute myelin breakdown, but usually not so intense as in
neoplastic lesions, and follow-upMRS exams will show distinct
patterns of metabolic changes in these two conditions (14).
An increase in creatine is also noted, and Choline was
elevated, possibly due to an increase in cell turnover and/or
myelin debris, as reported previously (15). NAA peaks may
be reduced within plaques, which is the most common and
remarkable ﬁnding, Cho and lactate are found to be increased
in the acute phase (15), this is in agreement with our cases in
the acute stage as elevation of glutamate and myoinositol
peak, and CHO/Cr ratio is noted in all cases (100%)
(Fig. 1). However, mild lac increase is noted in only one case
out of 4 (25%).
In Inactive or ‘chronic’ multiple sclerosis plaques, gluta-
mate levels were not different in non-enhancing chronic T1-
hypointense areas. We believe this is due to the absence of
activated immune cells in chronic plaques. However, NAA
was signiﬁcantly reduced in chronic T1-hypointense areas with
elevation of myoinositol. Both of these ﬁndings are consistent
with pathological evidence of reduced axonal density and glio-
sis (Fig. 2). Since NAA is consistently reduced in chronic
lesions (16) it would be important to ﬁnd predictors of this
decrease in the early enhancing phase of lesions. Chronic
plaques present reduced NAA/Cr ratios in the center of thebrain T2 FLAIR images showed right parietal hyperintense lesion,
(thin white arrow), mild raised level of myoinositol (thick white
omyelitis phase (A) Axial MRI brain T2 weighted images showed
and short TR showed: High choline/Cr, raised lactate peak, with
Fig. 4 Male patient 17 years old with brain TB (A, B & C) MRI axial T2 weighted image of the brain and MRS revealed: left frontal
subcortical intraaxial focus of altered signal intensity: MRS at long and short TR revealed. Well observed Glx peak (white arrow)
(Fig. 1A). Cho/Cr: 1.76, NAA/Cr: 0.98, MI/NAA: 0.567.
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or complete recovery of NAA signal in the periphery of the
lesion. This is in agreement with our chronic cases as Naa/
Cr ratios are reduced with mild elevation of MI in all cases
with reduced Glx in 10 out of 12 (83.33%) and mild elevation
in 2 out of 12 of chronic cases (16.66%) (Fig. 2).
In Acute disseminated encephalomyelitis (ADEM)
Reduced NAA/Cr ratios were detected during both the acute
and chronic phases while the Cho/Cr ratios were high dur-
ing the acute phase and decreased toward normal values
during the chronic phase (17). Major differences were found
between the acute and chronic phases in the mI/Cr ratio and
in the appearance of lipids and Glx. A marked reduction in
mI/Cr ratio was detected during the acute phase (Fig. 3) fol-
lowed by elevated values during the chronic phase in allFig. 5 Male patient 37 years old with encephalitis (A & B) MR
temporoparietal enhanced lesion, and MRS at long and short TR show
peak. Mild prominent MI peak, glutamate peak is noted (thin white apatients. The higher level of mI during the chronic phase
likely reﬂects a pathophysiological process of gliosis (18).
These results are matching with our results as in the acute
phase, and elevated lipids/lactate ratios were noted with
marked reduction in the MI/Cr that was detected in all cases
(Fig. 3). These peaks are normalized during the chronic
phase. However Glx peak is reduced in 4 out of 6 cases
(66.6%).
Tuberculous lesions have been shown to exhibit strong lipid
resonances, ascribed to mobile lipids within the caseous mate-
rial (19,20), which are minimally visible on MR imaging. The
diagnosis of a granuloma was based on the presence of high
lipid peak and Glutamine/Glutamate (Glx) peak (21,22). This
is in agreement with our tuberculoma cases, all showed high
(Glx) and lipid peak (Fig. 4).I and MRS axial post-contrast T1 weighted showed left deep
ed: Cho/Cr: 1.7, NAA/Cr. 2.11, Cho/NAA 0.47, prominent lip/lac
rrow).
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NAA and NAA/Cr, this reduction may be more signiﬁcant
in the chronic phase of encephalitis, and there can be gradual
recovery within 1 year. (23), ; Cr. " Cho, Cho/Cr, marked
increase in the Cho levels and Cho/Cr ratio can be seen in
encephalitis, particularly secondary to herpes virus because
of marked inﬁltration of macrophages. In this case, the spec-
tral pattern may resemble that of a neoplasm. Associated
increase in myoinositol (ml) should be suggestive of infection.
" ml, mI/Cr, this is a common ﬁnding in encephalitis and
relates to gliosis. Lipid/lactate peak may be seen. " Glutamate
and glutamine demonstrated (24).
These results are coincoiding with our cases of encephalitis
regarding the positive Glx and lipid/lactate peak and increased
Cho/Cr ratio compared to the normal side in 100% of cases
(Fig. 5).
Acetate, succinate and amino acid multiplet – composed of
valine, leucine and isoleucine – are markers of bacterial abscess
(25) and they are not detected in necrotic tumors such as
metastasis and glioblastoma, which sometimes mimic brain
abscess in conventional MR. Other types of abscess, such as
tuberculous, do not show this pattern. In addition, the charac-
teristic neural tissue peaks (NAA, Cho, Cre) are absent or
decreased, conﬁrming the brain tissue destruction in necroticFig. 6 Female patient 24 years old with brain abscess: (A & B) axia
hyperintense lesion with thin marginal enhancement in post-contrast stu
0.9 ppm(thickwhitedarrow), succinatepeakat2.4 ppm(thinwhitearrow
Fig. 7 Female patient 33 years old with brain cysticercosis, (A and B
revealed multiple widespread calciﬁed intra-axial lesions hyper and hy
(D) MRS at long and short TR revealed: There is reduction in the c
NAA/Cr: 1.53, A.A is mild elevated (thick white arrow), and succinatarea (26), and these results are coincoiding with all our cases
of brain abscesses that showed high succinate and amino acid
peak with reduced Cho/NAA and Cho/Cr ratios (Fig. 6).
Neurocysticercosis is the most common parasitic CNS
infection across the world. When the acute lesion is single,
parenchymatous, with reactive edema, it may simulate an ence-
phalic tumor (27). However, succinate signal is elevated in neu-
rocysticercosis and has been associated with the aerobic
metabolism of scolices, Amino acid peaks have also been
found in neurocysticercosis lesions (27), this is in agreement
with our cases of cysticercosis all showed elevated succinate
and mild raised A.A peak (Fig. 7).
Subacute infarction associated with lactate increase can be
detected in minutes after the ischemia and continues increasing
in the following hours (28,29). Choline might be elevated in
acute infarcts because of the high cellular turnover. Subacute
infarctions show decreased NAA (as a response to neuronal
loss and dysfunction) and increased lac, with progressive
Cho reduction in the chronic phase (30). High levels of
glutamate in plasma and cerebrospinal ﬂuid (CSF) have been
demonstrated in patients with acute ischemic stroke (31).
Subacute infarction could be from differentiated neoplasm
as follows: Increased lactate levels associated with reduced
NAA, Cr, and Cho levels. However, it is important tol T2 and post-contrast T1 weighted images: revealed right parietal
dy, (C &D)MRS at long and short TR revealed: raised A.A peak at
), raised lipid/lactatepeakandreducedCho/NAAandCho/Crratios.
) axial T2 weighted and post-contrast T1 WI images of the brain,
pointense on T2 WI and marginal contrast enhancement. (C) and
reatine due to high metabolic rate, Cho/NAA: 0.76, Cho/Cr: 1.3,
e peak at 2.4 ppm (thin white arrow).
240 R.O. Kaddah, M.E. Khalilremember that increased Cho levels may be observed in infarc-
tions especially in the chronic stages because of remyelination
and gliosis, and they should not be mistaken for a neoplasm.
This is in agreement with our study in all cases of subacute
infarct, regarding elevated lipid/lactate peak raised (Glx) peak
in the acute and subacute stage (Fig. 8) and its decrease in the
chronic stage (100%); however, we disagreed regarding low
choline level in chronic stage, as we had high level in chronic
stage in 7 out of 14 cases (50%) denoting remyelination and
gliosis.
Wilson disease (hepatolenticular degeneration) is an auto-
somal recessive disorder of copper metabolism. Glx is a neuro-
transmitter, generally increased in Wilson disease (32), which
coincoides and agrees with our results.
In MLD, there is elevated myoinositol/creatine and lactate/
creatine ratios as well as decreased N-acetyl aspartate/creatine
ratios. The mean of the Lac/Cr ratios in MLD cases was 0.42
compared to 0.11 in the control subjects. Elevated lac/Cr and
mI/Cr are both attributable to astrocytic gliosis ch/ch of
MLD elevation (33). Myoinositol and lactate may be used as
biomarkers for disease progression in MLD. We also noted a
slight elevation in the Cho/Cr, Inverted lactate doublet peak-Fig. 8 Male patient 57 years old with subacute hemorrhagic infarc
FLAIR images revealed left cortical and subcortical high signal intensit
(B & C) MRS at long and short TR revealed elevated Cho, reduced N
Fig. 9 Child male 3 years old with metachromatic leukodystroph
symmetrical conﬂuent areas of signal change in periventricular white m
and short TR shows high myoinositol (mI) level (thick white arrow) an
level, lac/Cr 0.32.increased choline peak and decreased NAAnCrea ratios with
conjunction to the pathognomonic brain MRI ﬁndings and
elevation of lactate in CSF, is enough to diagnose the disease
(33); the results are matching with all our cases MLD, they
showed high myoinositol (MI) level, raised lipid/lactate, MI/
Cr ratio, lac/Cr higher than 0.2 in all cases (Fig. 9).
Leigh’s disease one of many mitochondrial disorder also
known as subacute necrotizing encephalomyelopathy (SNEM)
symptoms becomes evident before the age of 2, with high T2
signal typically in brainstem, periaqueductal gray matter,
medulla, putamen, corpus striatum, globus pallidus, caudate
nuclei, substantia nigra, thalami, MR spectroscopy features
of elevated choline, occasionally elevated lactate, and reduced
NAA (34), this is in agreement with all our cases of Leigh’s dis-
ease that showed elevated lipid/lactate peak, elevated Chon-
crea ratio with reduced NAAnCr ratio (Fig. 10).
Excess glutamate in active lesions could therefore be an
important predictor of axonal injury, brain atrophy and
long-term accumulation of clinical disability (35). In infectious
disease the presence of Glx and MI peak with high lipid/lactate
supported the diagnosis. Succinate and amino acids are speciﬁc
for brain abscesses and cysticercosis. Other categories weretion presented with right sided weakness: ﬁndings: (A) axial T2
y lesion with multiply intralesional areas of altered signal intensity,
AA/Cr with high Glx (thick white arrow) and lipid lactate peak.
y (A): axial T2 FLAIR images of the brain revealed bilateral
atter with characteristic tigroid appearance, (B & C) MRS at long
d Glx (thin white arrow) (C), raised lipid/lactate with high MI/Cr
Fig. 10 Child female patient 3 years old with leigh’s disease: (A) MRI axial T2 FLAIR of the brain revealed bilateral deep white matter
hyperintense lesion, (B & C) MRS at long and short TR showed: Elevated lipid/lactate peak, elevated Cho/crea ratio. NAA/Cr ratio was
decreased.
MR Spectroscopy evaluation of white matter signal abnormalities 241differentiated by the pattern of ratios among NAA, Cre, Cho
and lac in conjunction with other imaging ﬁndings.
The limitation of our study is that single voxel MRS value
is limited in both resolution and anatomical coverage of white
matter lesions.
5. Conclusion
Proton MRS is a noninvasive additional MRI technique to
deﬁne the nature of non-neoplastic brain lesions. Together
with image analysis, it may be the key to etiologic diagnosis
or, at least, deﬁnition of the group where the lesion is classi-
ﬁed, by detecting changes in different metabolites and peaks
of inﬂammation.Conﬂict of interest
No conﬂict of interest.
References
(1) Haller S, Ko¨vari E, Herrmann FR, et al. Do brain T2/FLAIR
white matter hyperintensities correspond to myelin loss in normal
aging? A radiologic-neuropathologic correlation study. Acta
Neuropathol Commun 2013;1:14.
(2) Cianfonia A, Nikua S, et al. Metabolite ﬁndings in tumefactive
demyelinating lesions utilizing short echo time proton magnetic
resonance spectroscopy. AJNR 2007;28(February):272–7.
(3) Aydın H, Nilay O, Serdar S, Baki H, et al. The efﬁcacy and value
of proton MR spectroscopy in evaluating the brain tumours. New
J Med 2010:27–32.
(4) Aydın H, Sipahiog l, Aydın OE, et al. The value of proton mr-
spectroscopy in the differentiation of brain tumours from non-
neoplastic brain lesions. JBR–BTR 2011;94:1–10.
(5) Hartmann W, Herminghaus S, Krings T, Marquardt G, et al.
Clinical application of proton magnetic resonance spectroscopy in
the diagnosis of intracranial mass lesions. Neuroradiology
2002;44:371–81.
(6) Papanagiotou P, Grunwald IQ, Farmakis G, Hartmann KM,
et al. MR Spektroskopie bei entzu¨ndlichen Hirnerkrankungen.
Radiologe 2008;48:582–7.(7) Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W. Proton
magnetic resonance Spectroscopy of brain Tumours correlated
with pathology. Acad Radiol 2005;12:51–7.
(8) Papanagiotou P, Backens M, Grunwald IQ, Farmakis G, Politi
M, Roth C, et al. MR-Spektroskopie beiHirntumoren. Radiologe
2007;47:520–9.
(9) Narayana PA. Magnetic resonance spectroscopy in the monitor-
ing of multiple sclerosis. J Neuroimag 2005;15:46–57.
(10) Callot V, Galanaud D, Le Fur Y, Gouny SC, Ranjeva JP,
Cozzone PJ. H-MR spectroscopy of human brain tumours, a
practical approach. Eur J Radiol 2008;67:268–74.
(11) Sibtain NA, Howe FA, Saunders DE. The clinical value of proton
magnetic resonance spectroscopy in adult brain tumours. Clin
Radiol 2007;62:109–19.
(12) Nagar VA, Ye J, Xu M, Ng WH, Yeo TT, Ong PL, et al. Multi-
voxel MR spectroscopic imaging-distinguishing intracranial
tumours from non-neoplastic diseases. Ann Acad Med Singapore
2007;36:309–13.
(13) Mader I, Rauer S, Gall P, Klose U. H-MR spectroscopy of
inﬂammation, infection and ischemia of te brain. Eur J Radiol
2008;67:250–7.
(14) Katsavos Serafeim, Anagnostouli Maria. Biomarkers in Multiple
Sclerosis: an up to date overview: multiple sclerosis international,
vol. 13; 2013. p. 1–20.
(15) Helmz G. Volume correction for edema in single volume proton
MR spectroscopy in contrast enhancing multiple sclerosis lesions.
Magnet Reson Med 2001;46:256–63.
(16) Van Walderveen M, Barkhof F, Pouwels M, et al. neuronal
damage in T1 hypointense multiple sclerosis lesions demonstrated
in vivo using proton magnetic resonance spectrsoscopy. Ann
Neurol 1999;46:79–87.
(17) Aviva F, Ben S, Moran A. H-MRS for the diagnosis of acute
disseminated encephalomyelitis: insight into the acute-disease
stage. Pediatr Radiol 2009:1372–9, June.
(18) Lidia V, David J, Mary R, Wei H. Acute disseminated
encephalomyelitis: an MRI/MRS longitudinal study, vol. 30,
Issue 5, May 2004. p. 324–9.
(19) Grupta RK, Vatsal DK, Chawla S, et al. Differentiation of
tuberculous from pyogenic brain abscess with in vivo proton
spectroscopy and magnetization transfer MR imaging. Am J
Neuroradiol 2001;22:1503–9.
(20) Kumar A, Kaushik S, Tripathi RP, Kaur P, et al. Role of in vivo
proton MR spectroscopy in the evaluation of adult brain lesions:
our preliminary experience. Indian J Radiol Imaging 2009;19
(4):256–65.
242 R.O. Kaddah, M.E. Khalil(21) Richa T, Sona S, Rakesh K. Magnetic resonance imaging in
central nervous system tuberculosis. Magn Reson Med 2008;59
(3):475–84.
(22) Ramin Se´rgio L, Tognola W, et al. Proton magnetic resonance
spectroscopy: clinical applications in patients with brain lesions.
Sao Paulo Med J 2003;121(6):254–9 [online].
(23) Cendes F, Andermann F, Silver K, Arnold DL. Imaging of
axonal damage in vivo in Rasmussen’s syndrome. Brain
1995;118:753–8.
(24) Faria Andre´ia V, Fabiano R, Zanardi Veroˆnica A, Menezes Jose´
R, Cendes Fernando. The pattern of proton magnetic resonance
spectroscopy in non-neoplastic encephalic lesions. Arq Neuropsi-
quiatr 2004;62(2-B):429–36.
(25) lı´via T, Veroˆnica D, Andre´ia V, et al. Magnetic resonance
spectroscopy in the diagnosis and etiological deﬁnition of brain
bacterial abscesses. Arq Neuropsiquiatr 2007;65(4-b):1144–8.
(26) Garcia HH, Gonzalez AE, Evans CA, Gilman RH. Taenia solium
cysticercosis. Lancet 2003;16:547–56.
(27) Pandit S, Lin A, Gahbauner H, Libertin CR, Erdogan B, et al.
MR spectroscopy in neurocysticercosis. J Comp Assist Tom
2001;25:950–2.
(28) Dani KA, Warach S. Metabolic imaging of ischemic stroke: the
present and future. AJNR Am J Neuroradiol 2014;35, S37
Supplement 2014 www.ajnr.org S37–543.(29) Thomas RG, Dani KA, Chappell FM, et al. Systematic review of
perfusion imaging with computed tomography and magnetic
resonance in acute ischemic stroke: heterogeneity of acquisition
and postprocessing parameters: a translational medicine research
collaboration multicentre acute stroke imaging study. Stroke
2012;43(2):563–6.
(30) Dani K, An L, Henning EC, Shen J, et al. Multivoxel MR
spectroscopy in acute ischemic stroke: comparison to the stroke
protocol MRI. Stroke 2012;43(11):2962–7.
(31) Munoz maniega S, Cvoro V, et al. Changes in NAA and lactate
following ischemic stroke: a serial MR spectroscopic imaging
study. Neurology 2008;71(24):1993–9.
(32) Tarnacka B, Szeszkowski W, Gołebiowski M, Członkowska A.
Metabolic changes in 37 newly diagnosed Wilson’s disease
patients assessed by magnetic resonance spectroscopy. Parkin-
sonism Relat Disorder 2009;15(8):582–6.
(33) Mitra A, Jyuu W, Yadira V, Paola L. Multi-Voxel 1H-MRS in
Metachromatic Leukodystrophy. J Cent Nerv Syst Dis
2013;5:25–30.
(34) Aydan H, Volkan K, Baki H. Leigh syndrome: cranial MRI and
MR spectroscopy ﬁndings. Fırat Tıp Dergisi 2011;16(2):102–5.
(35) Radhika S, Napapon S, Ralph H, et al. Evidence of elevated
glutamate in multiple sclerosis using magnetic resonance spec-
troscopy at 3 T. Brain 2005;128:1016–25.
